IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eversept Partners, LP

Q2 2020 Holdings

Filed 2020-08-13 | 69 holdings | $729.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Pacira Biosciences(PCRX)ACOM695127100$7.0M132,6551.0%
Taro Pharmaceutical Inds LTDASHSM8737E108$7.0M105,1691.0%
Liquidia Technologies Inc(LQDA)ACOM53635D202$7.2M859,7241.0%
Amarin Corp PLCCallASPONS ADR NEW023111206$7.5M1,080,3001.0%
Select Sector Spdr TR(XLV)PutASBI HEALTHCARE81369Y209$8.0M80,0001.1%
Aurinia Pharmaceuticals Inc(AUPH)ACOM05156V102$8.9M548,3251.2%
Celldex Therapeutics Inc New(CLDX)ACOM NEW15117B202$9.3M712,6981.3%
Glaxosmithkline PLCASPONSORED ADR37733W105$9.3M227,2631.3%
Sarepta Therapeutics Inc(SRPT)ACOM803607100$11.5M71,7311.6%
Model N Inc(MODNEUR)ACOM607525102$11.8M340,7641.6%
Apellis Pharmaceuticals Inc(APLS)ACOM03753U106$13.7M420,9321.9%
Myovant Sciences LTDACOMG637AM102$15.7M760,5512.2%
Ensign Group Inc(ENSG)ACOM29358P101$17.9M427,3072.5%
Fate Therapeutics Inc(FATE)ACOM31189P102$18.2M531,2582.5%
Danaher Corporation(DHR)ACOM235851102$19.1M107,8572.6%
Biocryst Pharmaceuticals Inc(BCRX)ACOM09058V103$23.1M4,847,7923.2%
Deciphera Pharmaceuticals in(DCPHEUR)ACOM24344T101$25.0M418,6523.4%
Heska Corp(HSKAEUR)ACOM RESTRC NEW42805E306$26.1M280,2563.6%
Zogenix IncACOM NEW98978L204$27.2M1,007,0833.7%
United Therapeutics Corp del(UTHR)ACOM91307C102$28.2M232,6763.9%
Astrazeneca PLC(AZN)ASPONSORED ADR046353108$29.7M562,1514.1%
Ascendis Pharma A S(ASND)ASPONSORED ADR04351P101$32.6M220,3444.5%
Biohaven Pharmactl Hldg Co L(BHVN)ACOMG11196105$32.8M448,2644.5%
Amarin Corp PLCASPONS ADR NEW023111206$33.1M4,786,1014.5%
TG Therapeutics Inc(TGTX)ACOM88322Q108$48.7M2,501,2726.7%
Horizon Therapeutics PUB LTDASHSG46188101$53.1M954,7387.3%
Spdr S&P 500 ETF TR(SPY)PutATR UNIT78462F103$104.8M340,00014.4%
PreviousPage 2 of 2